17:36 ETThe Inner Circle acknowledges Shankari Thiagarajan as Pinnacle Professional of The Yearprnewswire·2 days ago, 04:37 PM4503ALPMY-1.54%
SMC recommends VEOZA for moderate to severe menopausal vasomotor symptomsPharmaTimes·Jul 13 at 07:07 AM4503ALPMY-1.54%
FDA approves Pfizer PADCEV-Keytruda combo for perioperative muscle-invasive bladder cancerPUBT·Jul 10 at 10:23 AMPFE+0.77%4503
Sangamo holds a bankruptcy sale; VCs back a China-linked Beam competitorbiopharmadive·Jun 24 at 09:32 AMMKKGY+1.44%SNY-0.98%
Sangamo Therapeutics Sets Stalking Horse Sales: $50M to Eli Lilly, Up to $50M to AstellasTradingView·Jun 23 at 07:53 AMSGMO0.00%ALPMY-1.54%
Inside Astellas CEO's plan to counter Xtandi’s patent cliffFiercepharma·Jun 11 at 05:02 PM4503ALPMY-1.54%
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer | PFE Stock NewsStockTitan·May 29 at 11:01 PMPFE+0.77%4503
Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth CompanyPR Newswire·May 26 at 01:45 AM4503
